White label ELPA - ClinicalTrials.eu

Study on the Effectiveness and Safety of Guselkumab and Ustekinumab for Patients with Moderate to Severe Crohn’s Disease

Not recruiting

4 1 1
Investigated diseases:
- Crohn’s disease
Investigated drugs:
- Ustekinumab
- Guselkumab
+7
Study on Fenebrutinib for Patients with Relapsing Multiple Sclerosis

Not recruiting

2 1
Investigated diseases:
- Relapsing multiple sclerosis
Study on Dostarlimab, Vitamin D3, and Drug Combination for Untreated Metastatic Pancreatic Cancer Patients

Not recruiting

2 1 1 1
Investigated diseases:
- Pancreatic carcinoma
- Pancreatic carcinoma metastatic
Investigated drugs:
Study of Cabozantinib for Patients with Advanced Renal Cell Carcinoma After Checkpoint Inhibitor Treatment

Not recruiting

2 1 1 1
Investigated diseases:
- Renal cell carcinoma
Investigated drugs:
- Cabozantinib
Study on the Effectiveness of Ivosidenib in Patients with IDH1 Mutated Myelodysplastic Syndrome

Not recruiting

2 1 1 1
Investigated drugs:
- Azacitidine
- Ivosidenib
Study on Organ Preservation for Early Stage Esophageal Cancer Using Durvalumab and Chemoradiation for Patients Eligible for Surgery

Not recruiting

2 1 1 1
Investigated diseases:
- Gastrooesophageal cancer
- Oesophageal adenocarcinoma
Investigated drugs:
Study on the Effectiveness of Cholecalciferol and Calcifediol in Treating Severe Vitamin D Deficiency in Patients

Not recruiting

3 1 1 1
Investigated diseases:
- Vitamin D deficiency
Investigated drugs:
- Calcifediol
- Colecalciferol
Study on Durvalumab with Radiochemotherapy for Patients with Locally-Advanced Anal Cancer

Not recruiting

2 1 1 1
Investigated diseases:
- Anal cancer stage II
- Anal cancer stage III
Investigated drugs:
- Durvalumab
Study on Durvalumab and Rintatolimod for Patients with Metastatic Pancreatic Cancer

Not recruiting

1 1 1 1
Investigated diseases:
- Pancreatic carcinoma metastatic
Investigated drugs:
- Rintatolimod
- Durvalumab
Study of Abemaciclib and Giredestrant for Patients with Early Stage ER-Positive, HER2-Negative Breast Cancer

Not recruiting

2 1 1 1
Investigated diseases:
- Breast cancer
Investigated drugs:
- Abemaciclib
- Giredestrant

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies